[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2141671A1 - Pyrimidine compound active on the central nervous system, process for preparing it and pharmaceutical compositions containing it. - Google Patents

Pyrimidine compound active on the central nervous system, process for preparing it and pharmaceutical compositions containing it.

Info

Publication number
ES2141671A1
ES2141671A1 ES009702698A ES9702698A ES2141671A1 ES 2141671 A1 ES2141671 A1 ES 2141671A1 ES 009702698 A ES009702698 A ES 009702698A ES 9702698 A ES9702698 A ES 9702698A ES 2141671 A1 ES2141671 A1 ES 2141671A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
preparing
nervous system
central nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009702698A
Other languages
Spanish (es)
Other versions
ES2141671B1 (en
Inventor
Clotet Joan Huguet
Acin Joan Roca
Rovira Anna Bosch
Bonet Merce Canovas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES9702698A priority Critical patent/ES2141671B1/en
Publication of ES2141671A1 publication Critical patent/ES2141671A1/en
Application granted granted Critical
Publication of ES2141671B1 publication Critical patent/ES2141671B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pyrimidine compound active on the central nervous system, process for preparing it and pharmaceutical compositions containing it. This invention relates to a compound of general formula I, its stereoisomer forms and mixtures thereof, and its pharmaceutically acceptable salts, a process for obtaining it and pharmaceutical compositions containing it. These compounds act as antagonists for dopamine D2 receptors and serotonin 5HT2 receptors and are effective in the treatment of schizophrenia and other related psychoses.
ES9702698A 1997-12-26 1997-12-26 ACTIVE PYRIMIDINIC COMPOUND ON THE CENTRAL NERVOUS SYSTEM, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. Expired - Lifetime ES2141671B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9702698A ES2141671B1 (en) 1997-12-26 1997-12-26 ACTIVE PYRIMIDINIC COMPOUND ON THE CENTRAL NERVOUS SYSTEM, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9702698A ES2141671B1 (en) 1997-12-26 1997-12-26 ACTIVE PYRIMIDINIC COMPOUND ON THE CENTRAL NERVOUS SYSTEM, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.

Publications (2)

Publication Number Publication Date
ES2141671A1 true ES2141671A1 (en) 2000-03-16
ES2141671B1 ES2141671B1 (en) 2001-01-01

Family

ID=8301630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9702698A Expired - Lifetime ES2141671B1 (en) 1997-12-26 1997-12-26 ACTIVE PYRIMIDINIC COMPOUND ON THE CENTRAL NERVOUS SYSTEM, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.

Country Status (1)

Country Link
ES (1) ES2141671B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0368388A2 (en) * 1988-11-07 1990-05-16 Janssen Pharmaceutica N.V. 3-Piperidinyl-1,2-benzisoxazoles
EP0453042A1 (en) * 1990-04-19 1991-10-23 Janssen Pharmaceutica N.V. Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
WO1995014691A1 (en) * 1993-11-23 1995-06-01 Janssen Pharmaceutica N.V. NOVEL 9-HYDROXY-PYRIDO[1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
WO1995023144A1 (en) * 1994-02-24 1995-08-31 Vita-Invest, S.A. Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0368388A2 (en) * 1988-11-07 1990-05-16 Janssen Pharmaceutica N.V. 3-Piperidinyl-1,2-benzisoxazoles
EP0453042A1 (en) * 1990-04-19 1991-10-23 Janssen Pharmaceutica N.V. Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
WO1995014691A1 (en) * 1993-11-23 1995-06-01 Janssen Pharmaceutica N.V. NOVEL 9-HYDROXY-PYRIDO[1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
WO1995023144A1 (en) * 1994-02-24 1995-08-31 Vita-Invest, S.A. Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Adv. Heterocyclic Chem., Vol. 6, 1996, R.E. LYLE y P.S. ANDERSON "The Reduction of Nitrogen Heterocycles with Complex Metal Hydrides". Pagina 55. *
J. JACQUES et al. "Enantiomers, Racemates and Resolutions", 1991, Krieger Publishing Company, Florida (USA). Paginas 263-266. *

Also Published As

Publication number Publication date
ES2141671B1 (en) 2001-01-01

Similar Documents

Publication Publication Date Title
MY139296A (en) CRYSTALLINE ß2 ADRENERGIC RECEPTOR AGONIST
MXPA05012678A (en) CRYSTALLINE FORM OF beta2.
ES2154167A1 (en) CCR-3 receptor antagonists
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
JO2371B1 (en) 4-phenyl -pyridine derivatives
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MY124390A (en) Substituted bicyclic derivatives useful as anticancer agents
MXPA05009367A (en) Opioid receptor antagonists.
CZ305838B6 (en) N-(2-arylethyl)benzylamines as 5-HT6 receptor antagonists
CA2246839A1 (en) Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
UA39168C2 (en) Fluoroalkoxyphenyl derivatives of pyperidine or quinuclidine AS antagonists of P substance and pharmaceutical composition based thereon
MXPA05011710A (en) Fused pyrimidine derivatives with crf activity.
PL361361A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
MX2007012936A (en) Dihydrobenzofuran derivatives and uses thereof.
ES2160525A1 (en) 4-aroyl-piperidin-ccr-3 receptor antagonists iii
YU53100A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
MY140835A (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
ES2158813A1 (en) Piperidine ccr-3 receptor antagonists
IL142893A0 (en) Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
CA2360308A1 (en) Glucocorticoid receptor modulators
HK1091200A1 (en) Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists
EP0915094A4 (en) Morphinane derivatives and medicinal use thereof
MXPA04005426A (en) Ring fused pyrazole derivatives.
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000316

Kind code of ref document: A1

Effective date: 20000316

FA2A Application withdrawn

Effective date: 20031120